Quick Comparison
| Gotu Kola | Noopept | |
|---|---|---|
| Half-Life | 2-4 hours (asiaticoside, madecassoside) | 30-60 minutes (active metabolite cycloprolylglycine persists longer) |
| Typical Dosage | Standard: 500-1000 mg standardized extract daily (triterpenes: asiaticoside, madecassoside). Traditional dose: 1-2 grams dried herb as tea. ECa 233 is a well-studied standardized extract. Can be taken morning or evening — mild enough for bedtime use. | Standard: 10-30 mg sublingually or orally, 2-3 times daily. Sublingual administration provides faster onset. Do not exceed 30 mg per dose. |
| Administration | Oral (capsules, extract, tea, tincture). ECa 233 standardized extract for consistent dosing. | Oral or sublingual (sublingual preferred for faster onset and higher bioavailability). Available as powder, capsules, or sublingual tablets. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
Gotu Kola
Triterpene saponins (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives. They increase BDNF expression in the hippocampus via CREB and ERK/MAPK pathways, promoting neuroplasticity, synaptogenesis, and memory formation. They enhance collagen type I synthesis through stimulation of fibroblasts and improve microcirculation via VEGF and angiopoietin modulation. Anxiolytic effects occur through positive allosteric modulation of GABA-A receptors (possibly at the benzodiazepine or neurosteroid site) and reduction of acoustic startle response (amygdala modulation). Gotu kola inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Anti-inflammatory effects come from NF-kB inhibition (IkB stabilization) and TNF-alpha suppression. Asiatic acid may also activate PPAR-gamma.
Noopept
Noopept modulates AMPA and NMDA receptors similarly to racetams through positive allosteric modulation. Its key distinguishing feature is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) via activation of TrkB and TrkA receptor signaling cascades — these neurotrophins are essential for neuronal growth, survival, dendritic arborization, and synaptic plasticity. Noopept inhibits glutamate-induced excitotoxicity by reducing calcium influx through NMDA receptors and modulating the NR2B subunit. It activates the PI3K/Akt and MAPK/ERK pathways downstream of neurotrophin receptors. The active metabolite cycloprolylglycine (a cyclic dipeptide) has endogenous nootropic activity, potentially acting as a trace amine-associated receptor ligand. Neuroprotection is further mediated through antioxidant effects and mitochondrial stabilization.
Risks & Safety
Gotu Kola
Common
Very well-tolerated. Mild GI upset, drowsiness.
Serious
Rare hepatotoxicity reported — avoid with liver disease and limit use to 6-week cycles.
Rare
Headache, dizziness, skin sensitivity to sunlight.
Noopept
Common
Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users.
Serious
No serious adverse effects documented.
Rare
Emotional blunting at high doses, insomnia, allergic reactions.
Full Profiles
Gotu Kola →
Centella asiatica is an Ayurvedic and Chinese medicine herb known as the 'herb of longevity.' It has been used for centuries to enhance memory, promote wound healing, and reduce anxiety. Modern research confirms it increases BDNF, enhances collagen synthesis, improves microcirculation, and has anxiolytic effects. Unlike most adaptogens, gotu kola has clinical evidence for improving memory and attention in healthy adults.
Noopept →
A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.